Login to Your Account



Other News To Note


Tuesday, August 7, 2012

• Astellas Pharma Inc., of Tokyo, disclosed plans to close subsidiary Urogenix Inc., of Durham, N.C., a research facility focused on urology drug discovery that was acquired in 2006 from Dynogen Pharmaceuticals Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription